| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品流通业(元) | 627,362,706.64 | 1,436,887,050.29 | 675,461,749.49 | 1,425,792,927.14 | 683,998,323.60 |
| 药品制造业及其他(元) | 329,946,699.52 | 623,127,592.36 | 332,666,458.61 | 768,003,811.04 | 399,855,832.28 |
| 营业成本(元) | |||||
| 药品流通业(元) | 551,850,466.32 | 1,243,238,871.17 | 585,666,886.68 | 1,241,520,556.36 | 595,547,137.41 |
| 药品制造业及其他(元) | 158,205,125.90 | 264,302,042.87 | 131,180,517.28 | 240,335,757.71 | 115,597,826.82 |
| 毛利(元) | |||||
| 药品流通业(元) | 75,512,240.32 | 193,648,179.12 | 89,794,862.81 | 184,272,370.78 | 88,451,186.19 |
| 药品制造业及其他(元) | 171,741,573.62 | 358,825,549.49 | 201,485,941.33 | 527,668,053.33 | 284,258,005.46 |
| 毛利率(%) | |||||
| 药品流通业(%) | 12.04 | 13.48 | 13.29 | 12.92 | 12.93 |
| 药品制造业及其他(%) | 52.05 | 57.58 | 60.57 | 68.71 | 71.09 |
| 收入构成(%) | |||||
| 药品流通业(%) | 65.53 | 69.75 | 67.00 | 64.99 | 63.11 |
| 药品制造业及其他(%) | 34.47 | 30.25 | 33.00 | 35.01 | 36.89 |
| 毛利构成(%) | |||||
| 药品流通业(%) | 30.54 | 35.05 | 30.83 | 25.88 | 23.73 |
| 药品制造业及其他(%) | 69.46 | 64.95 | 69.17 | 74.12 | 76.27 |